Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hypoxia × Ethiodized Oil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Carcinoma, Hepatocellular 2 Recurrence Hepatocellular Carcinoma 1 Neuroendocrine Tumors 1 Hypoxia 1

Interventions

TH 302 2 pomalidomide 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Injections 1 Ethiodized Oil 1 Dexamethasone 1 Cyclophosphamide 1 Bortezomib 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02174549 2024-11-22

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Teclison Ltd.

Phase 1/2 Recruiting

EndocrineGastrointestinalNET

Hypoxia, Carcinoma, Hepatocellular, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡